Kliiniset tutkimukset Nct sivu
Clinical Trial Results:
Ensayo clínico de fase III multicéntrico, randomizado, doble ciego, controlado con placebo, para comparar la eficacia de bevacizumab en combinación con rituximab y CHOP (RA CHOP) frente a rituximab y CHOP (R CHOP) en pacientes con linfoma difuso de células B grandes (LDCBG) CD20 positivo no tratados previamente. A multi-center, randomized, double-blind, placebo-controlled phase III trial omparing the efficacy of bevacizumab in combination with rituximab and CHOP (RA-CHOP) versus rituximab and CHOP (R-CHOP) in previously untreated patients with CD20-positive diffuse large B-cell lymphoma (DLBCL)
| Summary | |
EudraCT number | 2006-005520-16 |
Trial protocol | ES AT FR CZ GR PT GB SE DE IT PL SK LT HU |
Global completion date | 08 May 2012 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 08 Jul 2016 |
First version publication date | 22 May 2015 |
Other versions | |
Summary report(s) | BO20603 (CTg receipt) |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.